Good news: our stock tip column beat the market, for the fourth year in a row.

FORBES: Magazine Article

Adam Feuerstein from TheStreet.com seriously buries the lead in his Biotech Stock Mailbag column, waiting until page three to get to this gem.

FORBES: Biotech's Revolving Door

Back in early 2012, I wrote a column here about the stock option mega grant.

FORBES: Mega Stock Option Time Bombs Go Off at Sirius XM and Starbucks

The second column is when the stock fell right through the moving average and lost at least 5% within a month.

FORBES: Stocks Sitting Near Reliable Bouncing Point At 50-Day Average

The main leader column in the Times takes stock of the Labour party leadership race.

BBC: Papers

As of this writing, Apple stock is roughly where it was at the time of my last column prior to the earnings.

FORBES: Apple Earnings Provoke Initial Sound And Fury, Then Nothing And Worse

As I noted in my column last weekend, the Fed seemed to panic after the stock market plunged in August in its worst August in years, as economic reports continued to worsen.

FORBES: Bernanke Had To Brag About It, What He's Doin'

Numerous lawsuits were filed against Mr. Abelson, Barron's and its parent company, Dow Jones, most by executives and companies who felt their stock price had suffered by unfair revelations in Mr. Abelson's column.

WSJ: Alan Abelson, Longtime Barron's Columnist, Dies

In my mid-December column Stuff Those Stockings with Stocks, I featured a chart showing that stock ownership, despite the rally from the March 2009 lows, was still well below historically high levels ( see chart).

FORBES: Are You Ready For A Vegematic Market?

There were three common elements in about two-thirds of the emails: these investors were trading options and not the stock, they asserted that I knew nothing, and that it was foolish on my part to write such a column.

FORBES: Apple Earnings Provoke Initial Sound And Fury, Then Nothing And Worse